BJPsych:贫困儿童反应性依恋障碍患病率

2013-05-17 wangrui 医学论坛网

  经研究,反应性依恋障碍(Reactive Attachment Disorder,RAD)的发病与患者童年早期的受虐待经历有关。目前,尚缺乏对RAD在幼儿以外的其他人群中的患病率的研究资料。近期发表于《英国精神病学杂志》(The British Journal of Psychiatry)网络版的一项相关研究的结果显示,RAD在贫困儿

  经研究,反应性依恋障碍(Reactive Attachment Disorder,RAD)的发病与患者童年早期的受虐待经历有关。目前,尚缺乏对RAD在幼儿以外的其他人群中的患病率的研究资料。近期发表于《英国精神病学杂志》(The British Journal of Psychiatry)网络版的一项相关研究的结果显示,RAD在贫困儿童中并不罕见。

  研究对来自英国城市中心贫民区的1646名年龄在6-8岁之间的儿童进行了RAD症状筛查。采用半结构式访谈形式对高分和低分儿童的家长进行访问,收集相关精神病理学资料。对RAD疑似患者进行面对面评估。

  参与研究的92.8% 的老师和65.8%的 家长反馈了调查问卷结果。一半的研究资料来自于受试者,另一半缺失的的资料以基线数据为基础确定。对以上这些资料进行分析后,研究者发现其中的23名儿童明确符合RAD诊断。在此受试人群中,RAD的患病率约为1.40%(95%CI 0.94-2.10)。

障碍相关的拓展阅读:


Prevalence of reactive attachment disorder in a deprived population
Background
Reactive attachment disorder (RAD) is associated with early childhood maltreatment and has unknown population prevalence beyond infancy.
Aims
To estimate RAD prevalence in a deprived population of children.
Method
All 1646 children aged 6-8 years old in a deprived sector of an urban UK centre were screened for RAD symptoms. Parents of high and low scorers were interviewed using semi-structured interviews probing for psychopathology and individuals likely to have RAD were offered face-to-face assessment.
Results
Questionnaire data were available from 92.8% of teachers and 65.8% of parents. Assessments were conducted with 50% of those invited and missing data were imputed - based on the baseline data - for the rest. We calculated that there would be 23 children with definite RAD diagnoses, suggesting that the prevalence of RAD in this population was 1.40% (95% CI 0.94-2.10).
Conclusions
In this deprived general population, RAD was not rare.
Royal College of Psychiatrists

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1740491, encodeId=d4ac1e4049105, content=<a href='/topic/show?id=ffdc9242430' target=_blank style='color:#2F92EE;'>#贫困#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92424, encryptionId=ffdc9242430, topicName=贫困)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=192134785590, createdName=654699882_84926997, createdTime=Tue Aug 06 02:14:00 CST 2013, time=2013-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022767, encodeId=b9b42022e67b8, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Oct 18 21:14:00 CST 2013, time=2013-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250385, encodeId=c07c1250385a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sun May 19 00:14:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1740491, encodeId=d4ac1e4049105, content=<a href='/topic/show?id=ffdc9242430' target=_blank style='color:#2F92EE;'>#贫困#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92424, encryptionId=ffdc9242430, topicName=贫困)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=192134785590, createdName=654699882_84926997, createdTime=Tue Aug 06 02:14:00 CST 2013, time=2013-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022767, encodeId=b9b42022e67b8, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Oct 18 21:14:00 CST 2013, time=2013-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250385, encodeId=c07c1250385a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sun May 19 00:14:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1740491, encodeId=d4ac1e4049105, content=<a href='/topic/show?id=ffdc9242430' target=_blank style='color:#2F92EE;'>#贫困#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92424, encryptionId=ffdc9242430, topicName=贫困)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=192134785590, createdName=654699882_84926997, createdTime=Tue Aug 06 02:14:00 CST 2013, time=2013-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022767, encodeId=b9b42022e67b8, content=<a href='/topic/show?id=188b3e7309c' target=_blank style='color:#2F92EE;'>#反应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37730, encryptionId=188b3e7309c, topicName=反应性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Fri Oct 18 21:14:00 CST 2013, time=2013-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250385, encodeId=c07c1250385a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sun May 19 00:14:00 CST 2013, time=2013-05-19, status=1, ipAttribution=)]